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Vitamin D both facilitates and 
attenuates the cellular response to 
lipopolysaccharide
Ling Chen, Mathew Suji Eapen & Graeme R. Zosky
Vitamin D has a range of non-skeletal health effects and has been implicated in the response to 
respiratory infections. The aim of this study was to assess the effect of vitamin D on the response of 
epithelial cells, neutrophils and macrophages to lipopolysaccharide (LPS) stimulation. BEAS-2B cells 
(airway epithelial cell line) and primary neutrophils and macrophages isolated from blood samples were 
cultured and exposed to LPS with and without vitamin D (1,25(OH)2D). The production of IL-6, IL-8, 
IL-1β and TNF-α of all cells and the phagocytic capacity of neutrophils and macrophages to E. coli were 
assessed. Vitamin D had no effect on BEAS-2B cells but enhanced the production of IL-8 in neutrophils 
(p = 0.007) and IL-1β in macrophages (p = 0.007) in response to LPS. Both vitamin D (p = 0.019) and 
LPS (p < 0.001) reduced the phagocytic capacity of macrophages. These data suggest that the impact 
of vitamin D on responses to infection are complex and that the net effect will depend on the cells 
that respond, the key response that is necessary for resolution of infection (cytokine production or 
phagocytosis) and whether there is pre-existing inflammation.
Vitamin D is a secosteroid hormone which is well-known of its role in mineral and skeletal homeostasis1. A pleth-
ora of studies have suggested that vitamin D has a range of roles beyond the regulation of bone metabolism and 
that it plays a critical role in modulating the immune response; including the response to respiratory infections2. 
Respiratory tract infections (RTI), which are highly prevalent, are responsible for significant morbidity and mor-
tality, and are associated with the onset, progression and exacerbation of chronic lung diseases3,4.
Epidemiological studies have demonstrated strong associations between serum vitamin D levels and the 
incidence of RTIs5 and it has been suggested that the seasonal variations in vitamin D levels could explain the 
increased prevalence of RTIs in winter6, when vitamin D synthesis is low7. However, clinical trials with vitamin 
D supplementation have reported varying effects of on responses to respiratory infections8,9 such that current 
evidence linking vitamin D status and RTIs is equivocal.
Airway epithelial cells, as the first defensive barrier in the airway tract, play an important role in orchestrating 
neutrophil and macrophage recruitment to clear invading pathogens10. Neutrophils and macrophages play an 
important role in clearing pathogens through their phagocytic capacity by producing oxidants to kill engulfed 
microorganisms11. It is believed that the local production of 1α , 25-Dihydroxyvitamin D3 (1,25(OH)2D3), the 
active form of vitamin D, exerts protective effects during infections by upregulating the expression of cathelicidin 
and β defensin 2 in phagocytes12,13 and epithelial cells14. The clearance of pathogens and apoptotic cells by phago-
cytosis plays an important role in resolving inflammatory responses, and any impairment of these processes can 
lead to a chronic inflammatory state15.
While vitamin D is thought to be important in mediating the immune response to infection, as discussed 
above, the role of vitamin D in modulating cytokines production is unclear. Previous studies have shown con-
flicting effects (anti-inflammatory and pro-inflammatory) of vitamin D on the production of IL (interleukin) -1β , 
IL-6 and TNF (tumor necrosis factor) -α in response to a variety of insults16–18. IL-1β and TNF-α are essential 
for the activation of the epithelium and downstream inflammatory responses19. In addition, IL-1β , IL-6, IL-8 and 
TNF-α are involved in the innate immune responses by neutrophils and macrophages20 and may be influenced 
by vitamin D16–18,21.
Given the inconsistencies in the in vitro and clinical trial data, we aimed to determine the effect of exogenous 
vitamin D on the inflammatory response in key cells involved in the response to RTIs including epithelial cells, 
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macrophages and neutrophils. In order to achieve this, we examined whether vitamin D modulated the response 
to bacterial lipopolysaccharide (LPS).
Results
Cytokine production by BEAS-2B cells. 24 hours after exposure to LPS, the production of IL-6 (Fig. 1a, 
p < 0.001) and IL-8 (Fig. 1b, p < 0.001) was increased in BEAS-2B cells compared to controls. However, the mag-
nitude of the response was not altered by the presence of 1,25(OH)2D3 (IL-6, p = 0.552; IL-8, P = 0.994). IL-1β 
and TNF-α were not detectable by ELISA in any of the supernatants (data not shown).
Cytokine production by neutrophils. 24 hours after exposure to LPS, the production of IL-6 (Fig. 2b, 
p < 0.001), IL-8 (Fig. 2c, p < 0.001) and TNF-α (Fig. 2d, p = 0.002) was increased in neutrophils compared 
Figure 1. Production of IL-6 (a) and IL-8 (b) in the supernatant of BEAS-2B cells with (black bars) and without 
(white bars) LPS in the presence of vehicle or vitamin D (1,25(OH)2D3). Data are represented as mean (SD),  
*indicates p < 0.05, n = 4/group.
Figure 2. Production of IL-1β (a), IL-6 (b), IL-8 (c) and TNF-α (d) in the supernatant of neutrophils with 
(black bars) and without (white bars) LPS in the presence of vehicle or vitamin D (1,25(OH)2D3). Data are 
represented as mean (SD), *indicates p < 0.05, n = 9/group for IL-1β testing, n = 5/group for IL-6 testing, n = 8/
group for IL-8 testing, and n = 9/group for TNF-α testing.
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to controls. Interestingly, while 1,25(OH)2D3 had no effect on the production of IL-6 (p = 0.297) or TNF- α 
(p = 0.728) by the neutrophils, it increased the IL-8 response (p = 0.007) in both the LPS treated and untreated 
neutrophils. Neither LPS (p = 0.153) nor 1,25(OH)2D3 had any effect on IL-1β production (Fig. 2a, p = 0.600).
Cytokine production by macrophages. 24 hours after exposure to LPS, the production of IL-1β (Fig. 3a, 
p < 0.001), IL-6 (Fig. 3b, p < 0.001), IL-8 (Fig. 3c, p = 0.049) and TNF-α (Fig. 3d, p < 0.001) was increased in mac-
rophages compared to controls. In contrast to the neutrophils, while 1,25(OH)2D3 had no effect on the production 
of IL-6 (p = 0.531), IL-8 (p = 0.297) or TNF-α (p = 0.095), it increased the production of IL-1β (p = 0.001) in both 
the LPS treated and untreated cells.
Figure 3. Production of IL-1β (a), IL-6 (b), IL-8 (c) and TNF-α (d) in the supernatant of macrophages with 
(black bars) and without (white bars) LPS in the presence of vehicle or vitamin D (1,25(OH)2D3). Data are 
represented as mean (SD), *indicates p < 0.05, n = 7/group for IL-1β testing, n = 5/group for IL-6 testing, n = 7/
group for IL-8 testing, and n = 8/group for TNF-α testing.
Figure 4. Phagocytic capacity of neutrophils measured as the total phagocytosis of E. coli (a) or the percentage 
of cells that phagocytosed E. coli (b) in neutrophils treated with (black bars) or without (white bars) LPS in the 
presence of vehicle or vitamin D (1,25(OH)2D3). Data are represented as mean (SD), n = 6/group.
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Phagocytic capacity. There was no effect of LPS treatment or 1,25(OH)2D3 on total phagocytic capacity 
(Fig. 4a) (LPS, p = 0.732; 1,25(OH)2D3, p = 0.802) or the percentage of cells that engulfed the E. coli (Fig. 4b) 
(LPS, p = 0.788; 1,25(OH)2D3, p = 0.936) in neutrophils. In contrast, both LPS (p < 0.001) and 1,25(OH)2D3 
(p = 0.019) reduced the phagocytic capacity of macrophages (Fig. 5a). In the case of LPS and 1,25(OH)2D3, in iso-
lation, the effect seemed to be due to the reduced capacity of individual cells because the percentage of cells that 
phagocytosed E. coli was not changed in response to LPS (p = 0.516) or 1,25(OH)2D3 (p = 0.219) alone (Fig. 5b). 
However, in combination, LPS and 1,25(OH)2D3 significantly reduced the number of macrophages with phago-
cytic capacity (Fig. 5b, p < 0.001).
Discussion
Data on the effect of vitamin D deficiency on responses to respiratory tract infections are conflicting. We aimed 
to examine the effect of supplemental vitamin D on cytokine production and phagocytic capacity in three cell 
types that are important in the innate response to respiratory infections; airway epithelial cells, neutrophils and 
macrophages. We found that 1,25(OH)2D3, the active form of vitamin D, enhanced IL-8 and IL-1β production 
by neutrophils and macrophages respectively. 1,25(OH)2D3 also decreased the total phagocytic potential of mac-
rophages and, in combination with LPS, reduced the ability of individual macrophages to engulf E. coli. These 
data suggest that vitamin D has differing effects on the response to individual cell types to a bacterial stimulus. 
On the one hand the addition of vitamin D enhanced the production of cytokines but reduced the capacity of the 
macrophages to phagocytose pathogens. This may explain the conflicting associations between vitamin D and 
respiratory tract infections.
The airway epithelium is the first point of contact for invading pathogens in the respiratory tract. In response 
to bacterial stimuli, airway epithelial cells produce a range of pro-inflammatory mediators such as IL-6 and 
IL-822 which act to recruit mononuclear phagocytes23 and neutrophils24. These phagocytes play important roles 
in responding to, and clearing respiratory infections by phagocytosing and producing reactive oxygen species 
(ROS) to eliminate pathogens25. As expected, we saw increased production of IL-6 and IL-8 by airway epithelial, 
BEAS-2B, cells in response to LPS stimulation. These responses were not altered by vitamin D suggesting that 
vitamin D does not modulate important innate responses by epithelial cells to bacterial infections in the airway.
Macrophages and neutrophils are key cells in generating the innate immune response to invading pathogens. 
When a pathogen crosses the epithelial barrier and begins to replicate in the tissues of the host, it is immediately 
recognized by macrophages, that reside in the tissues, which, along with epithelial cells, produce chemokines to 
recruit large numbers of neutrophils to sites of infection10. Macrophages and neutrophils respond to pathogens, 
in part, by releasing a plethora of cytokines and chemokines in order to orchestrate the immune response26. 
Neutrophils have a high phagocytic capacity and, when a pathogen is engulfed, release IL-8, a neutrophil che-
moattractant27, which recruits additional neutrophils to site of infection24. Neutrophils also act to eliminate the 
pathogen by producing an oxidative burst28. As expected, we found that LPS increased the production of IL-8 by 
neutrophils. Interestingly, 25(OH)2D3 in our study facilitated the production of IL-8 suggesting that vitamin D 
may boost the capacity of neutrophils to respond to invading pathogens by recruiting additional neutrophils to 
the site of infection. This is in contrast to other studies on respiratory pathogens including tuberculosis where 
vitamin D had no effect on neutrophilia29. Similarly, vitamin D has been shown down-regulate IL-8 release in 
hyper-inflammatory macrophages21. The disparities in these observations suggest that the impact of vitamin D 
on the production of IL-8 by innate immune cells is dependent on the cell that is producing the cytokine and the 
infectious stimulus.
Activated macrophages produce a range of inflammatory mediators in response to bacterial infections. 
Consistent with previous studies30, we found that macrophages increased production of all the cytokines meas-
ured, IL-1β , IL-6, IL-8 and TNF-α , in response to LPS stimulation. However, pre-treatment with 1,25(OH)2D3 
during macrophage differentiation period facilitated LPS induced IL-1β production but had no effects on the 
Figure 5. Phagocytic capacity of macrophages measured as the total phagocytosis of E. coli (a) or the 
percentage of cells that phagocytosed E. coli (b) in macrophages treated with (black bars) or without (white 
bars) LPS in the presence of vehicle or vitamin D (1,25(OH)2D3). Data are represented as mean (SD), *indicates 
p < 0.05, n = 3/group.
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production of IL-6, IL-8 and TNF-α which is in contrast to a recent study which showed that 1,25(OH)2D3 sig-
nificantly reduced the levels of IL-6 and TNF-α in alveolar macrophages in response to a combination of LPS and 
IFN-γ 31. It is important to note that our study used differentiated PBMCs that were primed with vitamin D during 
differentiation rather than primary alveolar macrophage, so it is possible that the inconsistencies in these studies 
reflects different macrophage phenotypes. Again, this suggest that vitamin D can both potentiate and inhibit the 
inflammatory response under different conditions.
Our study is also in contrast to an early study which suggested that 1,25(OH)2D3 inhibits the proliferation of 
blood lymphocytes and IL-1 production32, however, recent studies, in line with our data, have found that vitamin 
D generally boosts infection-stimulated cytokine and chemokine responses; including enhanced IL-1β expres-
sion in macrophages18, enhanced macrophage survival and reduced mycobacterial burden by stimulating the 
anti-mycobacterial capacity of co-cultured lung epithelial cells. IL-1β exerts its protective action against infections 
by rapidly recruiting neutrophils to inflammatory sites. For example, IL-1 receptor knock-out mice recruit fewer 
neutrophils in response to influenza infection33. In addition, in vitro studies have shown that IL-1β restricts intra-
cellular Mycobacterium tuberculosis (M. tuberculosis) growth in murine and human macrophages by regulating 
TNF signalling and caspase-3 activation34. Similar to our observation in neutrophils, these data suggested that 
vitamin D enhances the capacity of macrophages to respond to bacterial stimuli.
Phagocytosis of pathogens by neutrophils and macrophages is one of their key functions35. While localiza-
tion of neutrophils to the site of inflammation is crucial for clearance of the infection, which vitamin D appears 
to enhance through increased IL-8 production, neither LPS nor vitamin D had any impact on the phagocytic 
capacity of neutrophils when challenged with E. coli. Interestingly, a previous study has clearly demonstrated 
that vitamin D enhances the phagocytic potential of macrophages that have low phagocytic capacity to live 
M. tuberculosis36. In contrast, our results have shown that both LPS and 1,25(OH)2D3 independently decreased 
the phagocytic capacity of individual macrophages to engulf E. coli with a decrease in overall phagocytosis (over-
all fluorescence) but approximately the same number of cells involved in phagocytosis. Interestingly, LPS and 
1,25(OH)2D3 together decreased the number of macrophages that were able to phagocytose E. coli. While there 
are several differences between these studies that may explain this difference, including the length of prior treat-
ment with vitamin D (2 vs 6 days), the pathogen used, and the length of pathogen challenge (45 minutes vs 
3 hours), these observation suggest that vitamin D is a potent modulator of the phagocytic capacity of mac-
rophages. In line with our data, in vivo studies have shown that mice injected with LPS had reduced phagocytic 
capacity in macrophages that may be due to the fact that the LPS drives macrophages to a more inflammatory, 
antigen presentation state37. There are numerous receptors involved in bacterial recognition by macrophages38, 
such that, if the macrophage receptors involved in phagocytosis are reduced, occupied, or internalized by stimuli, 
the phagocytic capacity can be attenuated39.
Other studies have shown that administration of vitamin D (10−8 M of 1,25(OH)2D3) had no effects on 
the phagocytic capacity of human alveolar macrophages, but increased the levels of the antimicrobial peptide 
cathelicidin (LL-37)31. We assessed LL-37 levels in the supernatants from our BEAS-2B cell and macrophage 
experiments and found that LL-37 levels were not increased in macrophages by pre-stimulation with vitamin D 
(10−7 M of 1,25(OH)2D3) during differentiation and were undetectable in BEAS-2B cells (Supplementary mate-
rial; Figure S1). This again highlights the importance of cell phenotype, and protocol, in influencing the cellular 
response to stimulation with vitamin D. Studies have shown that vitamin D has an effect on the morphology and 
function of monocyte-derived macrophages40 by inhibiting M1 macrophage activation and promoting M1-M2 
phenotype switching41,42. However, our data appear to contradict this and it possible that by priming with vitamin 
D during differentiation we facilitated M1 phenotype switching with increased the production of IL-1β . These 
data have important implications for the clearance of pathogens whereby the effect of vitamin D on macrophage 
phagocytosis and antimicrobial activity seems to be dependent on the type of pathogen, the period of exposure to 
vitamin D, the presence of pre-existing inflammation, and macrophage phenotype.
In conclusion, vitamin D exerted different effects on different cell types. While there was no effect of vita-
min D on LPS induced inflammation in epithelial cells, vitamin D enhanced the production of IL-8 in neutro-
phils and the production of IL-1β macrophages. Vitamin D had no effect on neutrophils phagocytic capacity but 
exaggerated the LPS induced decrease in macrophage phagocytic capacity. While acknowledging that we have 
studied these responses in isolation in vitro, and that these cells have the capacity to modulate 1,25(OH)2D levels 
in vivo through the upregulation of 25-hydroxyvitamin D-1α -hydroxylase (CYP27B1)43, our data demonstrate 
the complexity in understanding the effect of vitamin D on responses to infection. In some instances, the net 
effect of vitamin D on the response to infection may be neutral due to the competing effect of vitamin D on 
phagocytosis and the production of cytokines that are important in the resolution of infection. This area requires 
further investigation if we are to understand the complex role of vitamin D in the innate immune response.
Methods
Study subjects. Bronchial epithelial cells (BEAS-2B) were purchased from American Type Culture 
Collection (ATCC; Manassas, VA). Whole blood samples were collected from normal healthy (no acute or 
chronic illnesses) volunteers (aged 20–35 years; 5 males and 5 females) to isolate peripheral blood neutrophils 
and monocytes. The University of Tasmania Research Ethics Committee approved all the studies, and subjects 
gave written, informed consent. All methods were performed in accordance with the relevant guidelines and 
regulations.
Neutrophil and monocyte isolation. Neutrophils and human peripheral blood mononuclear cells 
(PBMCs) were isolated by density gradient centrifugation using Lympholyte-poly cell separation media 
(Cedarlane Labs, Burlington, Canada) composed of sodium diatrizoate and dextran 50044. 30 mL of freshly drawn 
blood was collected in Vacutainer collection tubes (BD, San Jose, CA) containing 15% K3EDTA solution and then 
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mixed at a ratio of 1:1 (vol/vol) with PBS at room temperature and 15 mL of the mixture was layered with 15 mL 
of Lympholyte-poly in a 50 mL tube. After centrifugation at 450 g for 35 min at 20 °C, neutrophils and PBMCs 
buffy coats were collected separately. Neutrophils buffy coats were washed with ice-cold HBSS (without Ca2+/
Mg2+) and centrifuged at 450 g for 5 min. The remaining red blood cells were lysed by hypotonic treatment with 
Red Blood Cell Lysis Buffer (Roche, Basel, Switzerland). This method has been show to yield samples of >95% 
neutrophils with >95% viability45. PBMCs buffy coats were washed with ice-cold PBS containing 0.1% BSA and 
2 mM EDTA and centrifuged at 450 g for 5 min. Monocytes were purified from freshly isolated PBMCs using 
MACS CD14 microbeads according to the manufacturer’s introductions (Miltenyi Biotec, Bergisch Gladbach, 
Germany), which are used for positive selection of human monocytes and macrophages from PBMCs46. Briefly, 
monocytes suspension was passed through the Pre-Separation filter then incubated with CD14 microbeads for 
15 min at 4 °C, to allow separation of CD14+ monocytes.
Cytokines. The concentrations of interleukin-1 beta (IL-1β ), interleukin-6 (IL-6), interleukin-8 (IL-8), and 
tumor necrosis factor alpha (TNF-α ) in the supernatants from the cell culture medium were measured using 
DuoSet ELISA kits (R&D Systems, Minneapolis, MN). The absorbance was read at 450 nm/570nm using a spec-
trophotometer (Spectramax M2, Molecular Devices, Sunnyvale, CA).
BEAS-2B inflammatory response. BEAS-2B cells were cultured in bronchial epithelial cell growth 
medium (BEGM) (Lonza, Walkersville, MD) at 37 °C in a 5% CO2 humidified incubator. BEAS-2B cells were 
seeded in 12-well plates at a density of 5 × 105 cells/mL with either 0.1% ethanol (vehicle control) or 10−7 M of 
1,25(OH)2D3 (Enzo Life Sciences, Farmingdale, NY) for 24 hours. After 24 hours, the culture media was changed, 
and cells were treated with 10 ng/mL of LPS (Sigma-Aldrich, St.Louis, MO) in the presence of vehicle control or 
10−7 M of 1,25(OH)2D3 for 24 hours at which point cell supernatants were collected for enzyme-linked immune 
sorbent assay (ELISA) assessment of IL-1β , IL-6, IL-8 and TNF-α .
Neutrophil inflammatory response. Isolated neutrophils were cultured in RPMI-1640 medium (Thermo 
Fisher Scientific, Waltham, MA) supplied with 10% fetal bovine serum (FBS) (Sigma-Aldrich, St.Louis, MO) and 
1% Penicillin-Streptomycin (Pen-Strep) (Sigma-Aldrich, St.Louis, MO) at 37 °C in a 5% CO2 humidified incu-
bator. Neutrophils were seeded in 12-well plates at a density of 1 × 106 cells/mL with either 0.1% ethanol (vehicle 
control) or 10−7 M of 1,25(OH)2D3 for 24 hours prior to treatment with 10 ng/mL of LPS in the presence of vehicle 
control or 10−7 M of 1,25(OH)2D3 for another 24 hours. Cells suspensions were centrifuged and the supernatant 
collected for ELISA assessment of IL-1β , IL-6, IL-8 and TNF-α .
Monocyte inflammatory response. The enriched CD14+ monocytes from PBMCs were cultured in 
RPMI-1640 medium supplied with 10% FBS and 1% Pen-Strep at 37 °C in a 5% CO2 humidified incubator. 
Monocytes were seeded in 12-well plates at a density of 5 × 105 cells/mL, and differentiated using 100 ng/mL of 
macrophage colony stimulating factor (M-CSF) (Sigma-Aldrich, St.Louis, MO) in the presence of vehicle control 
or 10−7 M of 1,25(OH)2D3 for 6 days with fresh 1,25(OH)2D3 added every day30. At day 7, M-CSF containing 
media was changed, and PBMCs differentiated macrophages were treated with 10 ng/mL of LPS in the presence 
of vehicle control or 10−7 M of 1,25(OH)2D3 for 24 hours. The supernatants were centrifuged and the supernatant 
collected for ELISA assessment of IL-1β , IL-6, IL-8 and TNF-α .
Phagocytic capacity of neutrophils and macrophages. Fluorescein conjugated Escherichia coli (K-12 
strain) (Thermo Fisher Scientific, Waltham, MA) was used to assess phagocytic capacity. Briefly, after 24 hours of 
stimulation with LPS, neutrophils or macrophages were incubated with Fluorescein conjugated E. coli at multi-
plicity of infection (MOI) of 5 for 45 minutes at 37 °C in a 5% CO2 humidified incubator. The reaction was stopped 
with ice. Cells were collected and washed 3 times with cold PBS, then phagocytes were fixed in 1% paraformal-
dehyde before been measured by flow cytometer BD FACSCANTO II (BD Biosciences, San Jose, CA). Optimal 
removal of macrophages required vigorous pipetting. Flow cytometry was performed to estimate the percentage 
of phagocytes which had engulfed bacteria and quantify the fluorescence intensities of E. coli in engulfed phago-
cytes. Flow cytometry data were analysed using FCS Express 6 (De Novo Software, Glendale, CA).
Statistical analysis. Group comparisons were made using two-way analysis of variance (Two-way ANOVA) 
with Holm-Sidak posthoc tests. Data were log-transformed where necessary to satisfy the assumptions of the test 
(normality and homoscedasticity). Data were analysed in SigmaPlot (Systat, Erkrath, Germany) and reported as 
mean (SD). P values of <0.05 were considered statistically significant.
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